ABSTRACT
Several dynamics have been operating in the pharmaceutical markets in the last few years that pose specialized challenges for the forecaster. Two of these challenges are the focus on specialty markets (or diseases) and the increasing role of biologics in disease treatment. This chapter discusses the implications of these trends on pharmaceutical forecasting.
